toxylact: a06ag04 glycerol

The first professional lActological database in the word

Rectal glycerol preparations classified in ATC class A06AG04 are considered compatible with breastfeeding, with negligible systemic absorption and minimal transfer into human milk when used at recommended doses for short‑term relief of constipation.sps+3

Pharmacological group and clinical use

Rectal glycerol (glycerin) in ATC A06AG04 belongs to the group of enemas used as laxatives for the short‑term treatment of constipation and for bowel emptying before procedures.atcddd.fhi+4
It acts locally in the distal bowel and is available as enemas and suppositories in various strengths for adults, children and infants.

Mechanism of action and toxicology

Glycerol is a colourless, viscous, sweet‑tasting polyol obtained from fats and widely used in medicines and foods, with very low intrinsic systemic toxicity at therapeutic doses.drugbank+2
Rectally, glycerol behaves predominantly as an osmotic laxative, increasing water content in the rectum and softening stool, and additionally exerts mild local irritant, stimulant and lubricating effects that promote defecation.pmc.ncbi.nlm.nih+4

Systemic absorption from the rectum is limited; most of the effect is local, and any absorbed fraction enters normal intermediary metabolism (conversion to glucose or triacylglycerols), so systemic toxic effects are rare at recommended doses.seslhd.nsw+2
Reported adverse effects are mainly local: rectal irritation, abdominal cramps, diarrhoea and, occasionally, minor bleeding related to insertion trauma rather than the molecule itself.pmc.ncbi.nlm.nih+2

In neonates and preterm infants, glycerol enemas or suppositories have been studied for facilitation of meconium passage and transition to enteral feeding; current evidence does not show clear clinical benefit and suggests a possible trend toward increased risk of necrotising enterocolitis, so use in this population should remain cautious and protocol‑driven.pubmed.ncbi.nlm.nih+3

Lactation pharmacology

Because rectal glycerol is poorly absorbed from the gastrointestinal tract and acts locally, maternal treatment results in very low or negligible levels in plasma and therefore in breast milk.sps+3
Specialist breastfeeding resources and product information state that glycerol suppositories can be used during breastfeeding; no clinically significant effects on the breastfed infant are expected, and no specific monitoring is usually required.medicines+3

Glycerol is an endogenous metabolite and a common excipient in oral and topical medicines and foods, further supporting its safety profile for lactating mothers and their infants when used in therapeutic rectal doses.drugbank+2
There are no reports of adverse developmental, neurological or gastrointestinal outcomes in breastfed infants directly linked to maternal use of glycerol enemas at usual doses.

Use in breastfeeding women: clinical considerations

For breastfeeding women with short‑term constipation, osmotic or bulk oral laxatives are often preferred first‑line, but rectal glycerol suppositories or enemas are acceptable options when rapid relief of hard stools in the rectum is required.medicines+3
Rectal glycerol should be used at the lowest effective dose and for the shortest duration, and combined with non‑pharmacological measures such as increased fluid intake, dietary fibre and physical activity.

Contraindications and cautions in breastfeeding are the same as in non‑lactating adults: known hypersensitivity, intestinal obstruction, severe inflammatory bowel disease, or unexplained abdominal pain of unknown origin.medicines+2
If maternal constipation is chronic or associated with alarm symptoms (rectal bleeding, weight loss, anaemia), further medical evaluation is required rather than repeated use of rectal glycerol.

Risk assessment for breastfed infants

Given the negligible systemic exposure of the mother and the absence of meaningful passage into milk, the relative infant dose of rectal glycerol is expected to be far below levels of concern, and no dose adjustment of breastfeeding or timing relative to feeds is necessary.sps+2
Theoretical infant risks (diarrhoea, abdominal discomfort) from any tiny ingested amounts via milk are extremely low, and routine observation of normal feeding, weight gain and stool pattern is sufficient.

In summary, rectal glycerol preparations in ATC class A06AG04 are compatible with breastfeeding, with a favourable safety profile when used appropriately for short‑term relief of constipation, and without evidence of clinically relevant toxicity for the breastfed infant.medicines+4

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.